Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Acquisitions, Strong Sales Keep Pfizer Dividend Strong
Investorplace
Monday, December 26, 2011 - 6:07pm
tags:
M&A, dividends, Pfizer
Cadence Pharmaceuticals: Good For Patients, Bad For Investors
Seeking Alpha
Monday, December 26, 2011 - 6:03pm
tags:
investors, Cadence Pharmaceuticals
Forbes Names The Best Big Drug Company Of 2011
Forbes
Monday, December 26, 2011 - 6:01pm
tags:
Bristol-Myers Squibb
A Reality Check on Three Hot Biotech Stocks: Oxygen Biotherapeutics (OXBT), NuPathe (PATH) & Adeona Pharmaceuticals (AEN)
Small Cap Network
Monday, December 26, 2011 - 9:00am
tags:
Adeona, NuPathe, Oxygen Biotherapeutics
Mead Johnson Says Its Tests Show Enfamil Baby Formula Is Safe
Bloomberg
Monday, December 26, 2011 - 8:53am
tags:
Mead Johnson, infant formula, Enfamil
Health Care's Worst Stocks 2011: Dendreon
Motley Fool
Monday, December 26, 2011 - 8:52am
tags:
Dendreon
DUSA Pharmaceuticals Is A Small Gem
Seeking Alpha
Monday, December 26, 2011 - 8:51am
tags:
DUSA pharmaceuticals, Levulan photodynamic therapy
New Dividend Kings: 5 High-Yield, Large Cap Pharma Stocks For 2012
Seeking Alpha
Monday, December 26, 2011 - 8:50am
tags:
dividends, JNJ, GSK, Pfizer, Merck, Bristol-Myers Squibb
Karo Bio Signs Research Pact With Pfizer for Autoimmune Diseases
Bloomberg
Monday, December 26, 2011 - 8:49am
tags:
Pfizer, Karo Bio, autoimmune disease
J&J opts out of HIV rights sharing pool
FT.com
Monday, December 26, 2011 - 8:48am
tags:
JNJ, HIV, Medicines Patent Pool
Geron's Hurry-Up-and-Wait Strategy
Motley Fool
Monday, December 26, 2011 - 8:46am
tags:
Geron, GRN1005, brain metastases, stem cells
Pfizer touts opioid trial results
Yahoo/Investors Business Daily
Friday, December 23, 2011 - 9:05am
tags:
Embeda, opioids, painkillers
Spike in approvals can't quell industry protests about the FDA
Fierce Biotech
Friday, December 23, 2011 - 9:03am
tags:
FDA, drug approvals
Dendreon demonstrates tougher commercialization hurdles for developers
Fierce Biotech
Friday, December 23, 2011 - 9:02am
tags:
Dendreon, Provenge
FDA panel to review Qnexa in February 2012
Drug Store News
Friday, December 23, 2011 - 8:59am
tags:
FDA, advisory panels, obesity, Qnexa, Vivus
Biotech Stock Mailbag: Most Important Events for 2012
TheStreet.com
Friday, December 23, 2011 - 8:56am
tags:
Oncothyreon, Keryx, Vical, Aeterna Zentaris, Eli Lilly, JNJ, Elan, Celgene, Pfizer, Gilead, Pharmasset, Threshold Pharmaceuticals, Celldex, Amgen, BioVex, Aveo Pharmaceutical, Amylin, Alkermes, Vertex, Cell Therapeutics, Amarin, ONYX Pharmaceuticals, Vivus
SkyePharma Shares Fall After Flutiform Application Fails to Win Consensus
Bloomberg
Friday, December 23, 2011 - 8:52am
tags:
SkyePharma, EMA, Europe, Flutiform, asthma
EU OKs Roche's Avastin for ovarian cancer
Reuters
Friday, December 23, 2011 - 8:50am
tags:
Europe, Avastin, ovarian cancer, Roche
Big Pharma buybacks, spinoffs cater to investors
Fierce Pharma
Friday, December 23, 2011 - 8:50am
tags:
spin-offs, stock buybacks, investors, Pfizer, GSK, Abbott Laboratories, AstraZeneca, Amgen, Teva Pharmaceuticals, Merck
6 Biotech Stocks With Consistently Rising Liquidity
Seeking Alpha
Friday, December 23, 2011 - 8:49am
tags:
Enzon, Immunogen, Micromet, Oncothyreon, Vivus, QLT

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.